Fred Alger Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.68M Buy
4,522
+2,431
+116% +$1.21M 0.01% 289
2025
Q4
$1.02M Sell
2,091
-2,171
-51% -$1.01M ﹤0.01% 360
2025
Q3
$1.79M Buy
+4,262
New +$1.43M 0.01% 327
2025
Q2
Sell
-832
Closed -$256K 479
2025
Q1
$256K Buy
+832
New +$285K ﹤0.01% 393
2023
Q2
Sell
-161
Closed -$36.1K 574
2023
Q1
$36.1K Sell
161
-183,352
-100% -$45.2M ﹤0.01% 474
2022
Q4
$51M Buy
+183,513
New +$46.3M 0.28% 106
2022
Q3
Sell
-82,844
Closed -$19.5M 566
2022
Q2
$19.5M Buy
+82,844
New +$16.8M 0.09% 174
2017
Q2
Sell
-7,000
Closed -$948K 576
2017
Q1
$948K Buy
+7,000
New +$1.06M ﹤0.01% 328
2016
Q3
Sell
-15,193
Closed -$1.61M 537
2016
Q2
$1.61M Sell
15,193
-15,559
-51% -$1.74M 0.01% 289
2016
Q1
$3.43M Sell
30,752
-20,834
-40% -$2.64M 0.02% 289
2015
Q4
$8.08M Sell
51,586
-223,399
-81% -$32.5M 0.04% 205
2015
Q3
$36.1M Sell
274,985
-300,073
-52% -$48.1M 0.2% 98
2015
Q2
$100M Buy
575,058
+18,381
+3% +$3.31M 0.45% 68
2015
Q1
$96M Buy
+556,677
New +$84.9M 0.43% 73

Other funds holding UTHR

Fred Alger Management's UTHR Position: Q1 2026 in Review

Fred Alger Management increased its United Therapeutics (UTHR) stake by 116% in Q1 2026, buying an estimated $1.21M and bringing the position to 4,522 shares worth $2.68M. The position accounts for 0.01% of the portfolio, ranked #289.

Fred Alger Management first reported a position in UTHR in Q1 2015 and has held it in 14 quarters since. The position peaked at $100M in Q2 2015. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Fred Alger Management held 4,522 shares of United Therapeutics worth $2.68M as of Q1 2026.
  • Fred Alger Management bought 2,431 United Therapeutics shares in Q1 2026, an estimated $1.21M.
  • United Therapeutics made up 0.01% of Fred Alger Management's portfolio in Q1 2026, its #289 holding.
  • Fred Alger Management first reported a position in United Therapeutics in Q1 2015 and has held it in 14 quarters since.
  • Fred Alger Management's United Therapeutics position peaked at $100M in Q2 2015.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.